Wegovy vs Ozempic: UK Guide to Semaglutide Differences

Both Wegovy and Ozempic are semaglutide—the same active ingredient. So why are there two names? Why do they cost differently? And which should you choose? This guide clears up the confusion.

The Core Truth: Same Drug, Different Licences

Semaglutide is manufactured by Novo Nordisk. The licensing authority (in this case, the EMA—European Medicines Agency) decided to:

• Ozempic — licensed for type 2 diabetes management
• Wegovy — licensed specifically for weight loss in people without diabetes

From a pharmacological standpoint, they're identical. The difference is regulatory and commercial.

Side-by-Side Comparison

| Factor | Ozempic | Wegovy | |--------|---------|--------| | Licensed for | Type 2 diabetes | Weight loss (non-diabetic) | | Maximum dose | 1.0 mg/week | 2.4 mg/week | | Typical dosing for weight loss | 1.0 mg/week | 1.7–2.4 mg/week | | NHS availability (England) | Diabetes only | Limited, waiting lists | | Private availability (UK) | Widely available | Increasingly available | | Private cost/month | £150–200 | £180–250 | | Titration schedule | Slower (8–12 weeks to 1.0 mg) | Faster (16 weeks to 2.4 mg) | | Injection pen | Single 1 mL pen | Multiple dose pens |

Why Two Names for the Same Drug?

Regulatory logic: When a drug is developed for a new indication (use), it typically goes through separate clinical trials. Novo Nordisk ran large trials (STEP 1–4) showing semaglutide's weight loss benefit in non-diabetic people. These trials used higher doses (up to 2.4 mg/week) than the diabetes trials.

To protect the integrity of the new indication and allow different dosing, the EMA approved it as a separate branded product: Wegovy.

Commercial logic: Separate branding allows different pricing, marketing, and positioning. Wegovy targets weight loss; Ozempic targets diabetes.

Dosing Differences Explained

Ozempic (Diabetes)

• Starting dose: 0.25 mg/week
• Titration: Increases every 4 weeks by 0.25 mg
• Maximum dose: 1.0 mg/week
• Timeline: Typically 8–12 weeks to reach therapeutic dose

Wegovy (Weight Loss)

• Starting dose: 0.25 mg/week
• Titration: Increases every 1–2 weeks by 0.25 mg increments
• Maximum dose: 2.4 mg/week
• Timeline: 16 weeks to reach full 2.4 mg dose

The higher Wegovy doses (1.7–2.4 mg/week) produce greater weight loss than Ozempic's maximum 1.0 mg—approximately 15–22% body weight loss vs. 8–15% with Ozempic at 1.0 mg.

Weight Loss Outcomes

Ozempic at 1.0 mg/week:

• Average weight loss: 8–15% body weight over 1 year
• Typical loss: 9–13 kg for a 90 kg person

Wegovy at 2.4 mg/week:

• Average weight loss: 15–22% body weight over 1 year
• Typical loss: 14–20 kg for a 90 kg person

The higher Wegovy dose is notably more effective, though side effects (particularly nausea) are also more pronounced at higher doses.

UK Private Clinic Prescribing Practices

Important: Most UK private clinics prescribe Ozempic for weight loss, even though it's licensed for diabetes. This is legal—off-label prescribing is routine and accepted in UK medicine.

Some clinics (Juniper, for example) now offer Wegovy specifically, which allows titration to the higher 2.4 mg dose. Others use Ozempic because:

• It's been available longer and has extensive safety data
• It's cheaper for both clinic and patient
• Many patients respond excellently at 1.0 mg

Cost implication: Expect private weight loss treatment (Ozempic or Wegovy) to cost £150–250/month indefinitely. NHS Wegovy, where available, is free but has long waits.

NHS vs Private: Which Semaglutide Will You Get?

NHS (England)

• Available: Wegovy (branded)
• Cost: Free, but long waiting lists (6–12+ months)
• Eligibility: BMI ≥35 with comorbidity, or BMI ≥30 with specialist assessment
• Duration: Usually 12-month cycles with reassessment

Scotland, Wales, Northern Ireland

• Policies vary; check your local health board
• Generally similar eligibility to England but implementation differs

Private

• Choice: Usually Ozempic (to 1.0 mg) or Wegovy (to 2.4 mg)
• Cost: £150–250/month
• Wait time: Days to weeks
• Duration: Can continue indefinitely as long as benefits outweigh costs

See our full NHS eligibility guide

Side Effects: Does Dosing Matter?

General rule: Higher doses = higher side effect rates.

Nausea: 40–50% at lower doses (Ozempic 1.0 mg), rising to 60% at Wegovy 2.4 mg Constipation: 20–30% at lower doses, 35–40% at higher doses Hair loss, fatigue: Similar incidence across dosing

Most side effects improve within 8–12 weeks. See our full side effects guide for management strategies.

Which Should You Choose?

Choose Ozempic (1.0 mg) if:

• You're starting GLP-1 treatment and want to assess tolerance first
• You're diabetic and want weight loss as a bonus benefit
• You want lower cost (slightly cheaper than Wegovy)
• You're sensitive to nausea and want to minimize it

Choose Wegovy (up to 2.4 mg) if:

• You want maximum weight loss and can tolerate higher doses
• You've tolerated Ozempic well and want to escalate
• Cost isn't a major concern
• You have time to titrate slowly (16 weeks is slower than it sounds)

NHS vs Private:

• NHS: Free if you qualify, but wait 6–12+ months
• Private: £150–250/month, immediate access, more flexibility

Key Takeaway

Ozempic and Wegovy are the same drug at different doses. In the UK, most weight loss seekers use Ozempic via private clinics because it's available now, well-understood, and works well. Wegovy offers higher doses and theoretically more weight loss, but at higher cost and more side effects.

The choice comes down to:

1. How much weight loss you want
2. Your side effect tolerance
3. Cost and access
4. How fast you want to start

Next Steps

• Compare UK private GLP-1 clinics
• Managing GLP-1 side effects
• Nutrition on GLP-1
• Check NHS eligibility

---

As an Amazon Associate I earn from qualifying purchases.

Disclaimer: This is educational information, not medical advice. Always consult your GP or prescriber before starting or changing GLP-1 medications.